Carlo Sebello, NP
Primary Care · Jersey City, NJNPI 1801556857
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 349 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $3,318 and has fallen 88.4% since, to $384 in 2025. Among primary care clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 349 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Lilly USA, LLC$849
- GSK$802
- Novo Nordisk$795
- AstraZeneca$778
- Johnson & Johnson$757
- plus $3K from 28 others
What the payments were for
- Food & beverage$7,949100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 40 | $1,200 |
| Lilly USA, LLC | 48 | $849 |
| GSK | 39 | $802 |
| Novo Nordisk | 47 | $795 |
| AstraZeneca | 32 | $778 |
| Johnson & Johnson | 41 | $757 |
| Boehringer Ingelheim | 15 | $751 |
| Intra-sana Laboratories | 7 | $464 |
| Scilex Pharmaceuticals Inc. | 13 | $193 |
| Intuity Medical Inc | 3 | $169 |
| Sanofi-aventis U.S. LLC | 2 | $146 |
| AbbVie | 8 | $127 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $121 |
| Ardelyx, Inc. | 6 | $116 |
| Bayer | 5 | $111 |
| Novartis | 6 | $102 |
| Merck | 4 | $58 |
| Amarin Pharma, Inc. | 4 | $58 |
| Exact Sciences | 2 | $51 |
| Ironwood Pharmaceuticals, Inc | 2 | $40 |
| Azurity Pharmaceuticals, Inc. | 2 | $30 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Renalytix AI, Inc. | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Althera Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$613
- Reltone 200 Mg$406
- GLYCATE$406
- Reltone 400 Mg$406
- Repatha$398
- Otezla$375
- XARELTO$243
- FARXIGA$151
- BREZTRI$151
- AIRSUPRA$151
- SOLIQUA 100/33$130
- MOUNJARO$125
- FASENRA$125
- TRELEGY ELLIPTA$122
- Ozempic$120
How this compares
$7,949 in reported general payments places this provider in the 95th percentile of 330 primary care providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 136 | $182,879 |
| OzempicSemaglutide | 80 | $163,038 |
| OtezlaApremilast | 11 | $147,357 |
| JanuviaSitagliptin Phosphate | 110 | $145,105 |
| JardianceEmpagliflozin | 108 | $138,151 |
| RybelsusSemaglutide | 52 | $121,555 |
| Xigduo XrDapaglifloz Propaned/Metformin | 94 | $112,076 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 91 | $111,314 |
| TrulicityDulaglutide | 44 | $90,714 |
| LinzessLinaclotide | 54 | $55,472 |
| MounjaroTirzepatide | 31 | $50,425 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 54 | $43,521 |
| VascepaIcosapent Ethyl | 84 | $42,885 |
| EliquisApixaban | 26 | $38,392 |
| Bydureon BciseExenatide Microspheres | 22 | $29,501 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $795 | $284,593132 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy | $751 | $278,918228 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $778 | $212,087163 claims |
| AmgenOtezla, Prolia | $1,200 | $169,44024 claims |
| MerckJanuvia, Segluromet | $58 | $155,279126 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $849 | $141,13975 claims |
| AbbVieLinzess | $127 | $55,47254 claims |
| GSKTrelegy Ellipta, Shingrix | $802 | $46,69771 claims |
| PfizerEliquis | $17 | $38,39226 claims |
| Johnson & JohnsonXarelto | $757 | $18,45218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 330 primary care providers in New Jersey.
Other primary care in Jersey City
- Mary Grace TolentinoJersey City$9K
- Stephanie CorpronJersey City$3K
- Michael Zito GovertNeptune$61K
- Roseann BenantiEnglewood$24K
- Marcelo MarinEnglewood$17K
- Jennifer EdwardsPrinceton$14K
- Kevin Robert ReyladoNorth Arlington$8K
- Karam WehbehPaterson$7K
- Shazam BacchusNewark$7K
- Anna NievesBasking Ridge$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.